gastroparesis - Nursing Case Study
Pathophysiology
• Primary mechanism: Impaired gastric motility due to vagus nerve dysfunction, often secondary to diabetes mellitus, reduces gastric emptying efficiency, leading to delayed food passage into the duodenum.
• Secondary mechanism: Dysfunction of the interstitial cells of Cajal, which act as pacemakers for gastric contractions, further exacerbates impaired motility and contributes to erratic gastric peristalsis.
• Key complication: Chronic gastroparesis can result in severe nutritional deficiencies and weight loss, as well as significant glycemic control challenges in diabetic patients due to unpredictable gastric emptying.
Patient Profile
Demographics:
45-year-old female, teacher
History:
• Key past medical history: Type 1 Diabetes Mellitus for 20 years, hypothyroidism, previous episodes of diabetic ketoacidosis
• Current medications: Insulin glargine, insulin lispro, levothyroxine, metoclopramide, ondansetron
• Allergies: Penicillin (rash)
Current Presentation:
• Chief complaint: Severe nausea and vomiting
• Key symptoms: Abdominal bloating, early satiety, unintentional weight loss of 10 lbs over the past month, severe fatigue
• Vital signs: Blood pressure 90/60 mmHg, heart rate 115 bpm, respiratory rate 24 breaths per minute, temperature 100.4°F, oxygen saturation 92% on room air
Section 1
As the nursing team conducts an initial assessment, the patient's severe dehydration and electrolyte imbalances become apparent. Laboratory results show a significant elevation in blood glucose levels at 350 mg/dL, despite regular insulin administration, pointing to the unpredictable gastric emptying's impact on insulin absorption and glycemic control. Serum electrolyte analysis reveals hypokalemia (potassium level of 2.8 mEq/L) and hyponatremia (sodium level of 128 mEq/L), which could further complicate her cardiac and neurological status given her current tachycardia and hypotension. Notably, her hemoglobin A1c is elevated at 10.2%, reflecting chronic poor glycemic management likely exacerbated by the gastroparesis.
The physical examination reveals dry mucous membranes, poor skin turgor, and diffuse abdominal tenderness upon palpation, with hypoactive bowel sounds. Despite the administration of ondansetron, her nausea persists, complicating oral intake and further contributing to her weight loss and nutritional deficits. The patient also demonstrates orthostatic hypotension, with a significant drop in blood pressure upon standing, indicative of her severe volume depletion. These findings suggest an acute exacerbation of her gastroparesis, necessitating careful fluid and electrolyte replacement, along with potential adjustments to her diabetic management plan to prevent further complications.
To address these challenges, the medical team considers introducing jejunal feeding to bypass the dysfunctional stomach, ensuring better nutritional delivery and glycemic control. Additionally, the possibility of utilizing a gastric neurostimulator device is discussed, aiming to improve gastric motility and symptom management. However, the patient’s current instability necessitates immediate stabilization efforts, including intravenous fluid resuscitation, electrolyte repletion, and close monitoring of cardiac and neurological status due to her electrolyte derangements. These interventions are critical to prevent further deterioration and stabilize her condition, setting the stage for more definitive long-term management strategies.
Section 2
As the medical team initiates stabilizing interventions, the patient's response to treatment is closely monitored. Initial intravenous fluid resuscitation with isotonic saline begins to address the severe dehydration, and electrolyte repletion is cautiously administered to correct hypokalemia and hyponatremia. Over the next few hours, the patient's vital signs are carefully tracked: her tachycardia begins to decrease from 120 bpm to 98 bpm, and her blood pressure stabilizes at 100/60 mmHg, although she remains orthostatic. Serum potassium levels increase to 3.4 mEq/L, and sodium levels rise to 132 mEq/L, indicating partial correction of her electrolyte imbalances. Despite these improvements, the patient continues to experience persistent nausea and abdominal discomfort, suggesting that gastric stasis remains a significant issue.
Concurrent with fluid management, the healthcare team decides to initiate continuous jejunal feeding, providing a controlled introduction of nutrition and insulin to bypass the gastric dysfunction. However, as this intervention is implemented, new diagnostic results reveal an unexpected complication: a computed tomography (CT) scan shows evidence of gastric bezoar formation, likely contributing to gastric outlet obstruction and exacerbating her gastroparesis symptoms. This finding necessitates a reevaluation of the current treatment plan and prompts a discussion about potential endoscopic removal of the bezoar to alleviate obstruction and improve gastric emptying.
As the team prepares for possible endoscopic intervention, the patient's glycemic control remains a challenge. Despite adjustments in insulin dosing coordinated with jejunal feeding, her blood glucose levels fluctuate widely, with readings ranging from 250 mg/dL to 400 mg/dL. The elevated hemoglobin A1c of 10.2% further underscores the complexity of managing her diabetes in the context of gastroparesis. The team considers integrating a continuous glucose monitoring system to provide real-time feedback and guide more precise insulin titration. This multifaceted approach aims to stabilize her condition and lay the groundwork for long-term management, while remaining vigilant for any new complications that may arise in this intricate clinical scenario.
Section 3
As the medical team navigates the complexity of the patient's condition, a change in her status prompts further evaluation. Despite initial improvements in hydration and electrolyte balance, the patient exhibits increasing signs of distress. She reports a sharp increase in abdominal pain, now rated at 8 out of 10 on the pain scale, and displays visible abdominal distension. Her vital signs reveal a concerning trend: her heart rate has climbed back to 110 bpm, and her blood pressure has dropped to 92/58 mmHg, indicating potential hemodynamic instability. The nursing staff notes a decrease in urine output to 20 mL/hour, raising alarms about her renal perfusion status.
Given these developments, the team considers the possibility of acute gastric perforation or exacerbation of the gastric outlet obstruction due to the bezoar. An urgent consultation with gastroenterology leads to an expedited esophagogastroduodenoscopy (EGD). During the procedure, a large, hardened bezoar is visualized and successfully fragmented using endoscopic techniques, which is anticipated to relieve the obstruction. However, the EGD also reveals signs of gastric mucosal ischemia, likely a result of prolonged stasis and elevated intragastric pressures.
In parallel, the patient's fluctuating blood glucose levels demand immediate attention. The team revises the insulin regimen, incorporating both basal and bolus insulin adjustments informed by the continuous glucose monitoring system. This strategy aims to achieve tighter glycemic control, crucial for her recovery and prevention of further complications. As she transitions from the acute phase to more stable footing, the focus shifts to comprehensive management strategies, including dietary modifications, prokinetic medications, and ongoing monitoring for signs of recurrent obstruction or ischemia. The team remains vigilant, aware that her journey will require careful coordination of multidisciplinary care to address the intertwined challenges of gastroparesis, bezoar formation, and diabetes management.
Section 4
As the medical team continues to closely monitor the patient following the endoscopic intervention, the focus turns to her response to the recent fragmentation of the bezoar and the management of her gastroparesis. Over the next 24 hours, the team observes some encouraging signs: the patient's abdominal distension begins to decrease, and her pain level drops to a more manageable 5 out of 10. However, her clinical picture remains complex. Her vital signs show persistent tachycardia, with a heart rate hovering around 105 bpm, and her blood pressure remains borderline at 94/60 mmHg. Although urine output has improved slightly to 25 mL/hour, it still raises concerns about her renal function and perfusion.
New laboratory results provide further insights into her condition. Her serum lactate levels are elevated at 3.5 mmol/L, suggesting ongoing tissue hypoperfusion despite intervention. Additionally, her complete blood count reveals a mild leukocytosis with a white blood cell count of 14,000/mm³, which may indicate an inflammatory response secondary to the gastric ischemia or a possible infection. Electrolyte analysis shows a slight drop in potassium levels, now at 3.2 mEq/L, necessitating cautious supplementation to avoid further complications.
In light of these findings, the medical team deliberates on the next steps. The possibility of sepsis is considered, prompting the initiation of broad-spectrum antibiotics while awaiting further cultures. The team also decides to intensify fluid resuscitation efforts, carefully balancing the need for adequate hydration against the risk of exacerbating her gastroparesis. Prokinetic therapy is adjusted to optimize gastric motility, and frequent reassessments are scheduled to closely monitor her response. The complexity of her case underscores the need for ongoing interdisciplinary collaboration, as the team navigates the intricacies of her multifaceted condition with a strategic and vigilant approach.
Section 5
As the medical team continues to manage the patient's complex case of gastroparesis with multiple complications, a new complication emerges that demands urgent attention. Over the next 12 hours, the patient's respiratory status begins to deteriorate, as evidenced by an increasing respiratory rate, now at 28 breaths per minute, and a decreasing oxygen saturation, currently at 89% on room air. Auscultation of the lungs reveals diminished breath sounds in the lower lobes bilaterally, suggesting possible atelectasis or the development of a pleural effusion. This change prompts the team to order a chest X-ray for further evaluation and to consider supplemental oxygen to maintain adequate oxygenation.
The imaging results are revealing: the chest X-ray indicates bilateral pleural effusions, more pronounced on the right side, which could be contributing to the patient's hypoxemia. These findings raise concerns about fluid overload as a consequence of aggressive fluid resuscitation, necessitating a reevaluation of the fluid management strategy. In response, the team decides to initiate diuretic therapy to mitigate the effusions and closely monitors the patient's fluid status with serial assessments of central venous pressure and repeat electrolyte panels. The balance between correcting hypovolemia and avoiding pulmonary complications becomes a critical focus of the treatment plan.
The patient's evolving condition requires advanced clinical reasoning to navigate the interplay between her gastroparesis and the new pulmonary issues. The medical team engages in a multidisciplinary discussion to refine her management plan, considering the need for potential thoracentesis if the effusions do not resolve with diuretics. Additionally, the team explores the possibility of utilizing non-invasive ventilation support to improve her respiratory function while continuing the current antibiotic regimen to address the risk of sepsis. This newfound complexity in her clinical picture underscores the fluid nature of her condition, necessitating vigilant monitoring and adaptive strategies to optimize her care and recovery trajectory.